Misra Saumya, Gupta Amit, Symes Andrew, Duncan John
1Department of Urology, Princess Royal Hospital, Brighton & Sussex University Hospitals NHS Trust , Haywards Heath , UK.
Scand J Urol. 2014 Jun;48(3):328-30. doi: 10.3109/21681805.2013.836724. Epub 2013 Sep 27.
Abstract Intravesical bacille Calmette-Guérin (BCG) is used to treat high-risk superficial bladder cancer. This article reports a case of secondary haemophagocytosis after intravesical BCG instillation in a 70-year-old man with bladder cancer and presents a literature review of this very rare but potentially fatal complication of intravesical BCG treatment.
摘要 膀胱内灌注卡介苗(BCG)用于治疗高危浅表性膀胱癌。本文报告了一例70岁膀胱癌男性患者在膀胱内灌注BCG后发生继发性噬血细胞综合征的病例,并对膀胱内BCG治疗这种非常罕见但可能致命的并发症进行了文献综述。